MLXIPL and neoplasm: Interestingly, the loss of ChREBPα alone in liver-ChREBP-KO mice seems more tumor-protective than the loss of both isoforms, suggesting that the enhanced glycolysis driven by ChREBPα particularly promotes tumor progression, while ChREBPβ may mediate tumor-suppressive effects.